ArticleCancer cell international2026

An integrative framework combining Mendelian randomization, single-cell profiling, and experimental validation identifies FTMT as a mitochondrial-immune regulator in non-small cell lung cancer.

Shouyong Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.